Committee

Full Name	Position	Organization	Term Start	Term End
Keith Wonnacott, PhD	Chair	Lexeo Therapeutics	6/1/2021	5/31/2022
Angela N. Johnson, MBA MS	Member	Sigilon	6/1/2021	5/31/2024
Adora Ndu, JD, PhD	Member	BioMarin Pharmaceutical	6/1/2021	5/31/2022
Scott V. McGoohan, JD, BS	Member	Vertex Pharmaceuticals	6/1/2019	5/31/2022
Jan E. Thirkettle	Member	Platform Strategy Consulting Ltd	6/1/2020	5/31/2023
Juliana Muscat, PhD	Member	Vertex Pharmaceuticals	6/1/2019	5/31/2022
Victor Paulus, PhD	Member	Abeona Therapeutics	6/1/2019	5/31/2022
Michael Havert, PhD	Member		6/1/2019	5/31/2022
Daniela Drago, PhD	Member	Aurion Biotech	6/1/2020	5/31/2023
Megan Zoschg Canniere, PharmD	Member	Spark Therapeutics	6/1/2020	5/31/2023
Kit L. Shaw, PhD	Member	Dana-Farber Cancer Institute	6/1/2019	5/31/2022
Timothy K. MacLachlan, PhD	Member	Novartis	6/1/2021	5/31/2024
S. Kaye Spratt, PhD	Member	BridgeBio Gene Therapy	6/1/2019	5/31/2022
Kathleen Meyer	Member	Sangamo Therapeutics, Inc.	6/1/2016	5/31/2022
Anna R. Kwilas, PhD	Member	Food and Drug Administration	6/1/2016	5/31/2022
Robert G. Pietrusko	Member	Voyager Therapeutics, Inc.	6/1/2019	5/31/2022
Sandhya Sanduja	Member	US Food and Drug Administration	6/1/2019	5/31/2022
Samantha Kay	Staff Liaison	ASGCT	6/1/2018	5/31/2045
Caitlin McCombs	Staff Liaison	ASGCT	12/1/2021	5/31/2045